Apollomics Reports Top-line Data from P-III Bridging Study of Uproleselan in Chinese Patients with R/R Acute Myeloid Leukemia (AML...
Shots: Apollomics has reported topline data from the P-III bridging study assessin...
Arrowhead Pharmaceuticals Commences P-I/IIa Trial of ARO-INHBE to Treat Obesity
Shots: Arrowhead has dosed the first patients with ARO-INHBE (RNAi therapy) in P-I...
GSK Reports the Data from the P-III (FIRST-ENGOT-OV44) Study Evaluating Zejula and Jemperli in 1L Advanced Ovarian Cancer
Shots: GSK reported data from the P-III (FIRST-ENGOT-OV44)study
Regeneron Reports Results from P-II (ROXI-VTE-I and ROXI-VTE-II) Trials of REGN7508 and REGN9933 for Venous Thromboembolism
Shots: The P-II (ROXI-VTE-I) study assessed REGN9933 (IV) vs enoxaparin (QD) &...
Roche Reports the P-IIb (PADOVA) Trial Data of Prasinezumab for Early-Stage Parkinson’s Disease
Shots: The P-IIb (PADOVA) study assessed safety & efficacy of prasinezumab (15...
